The Oncotype IQ Genomic Intelligence Platform

Oncotype IQ Journey

Making Cancer Care Smarter

As the world's leading provider of genomic-based diagnostic tests, we're committed to making cancer care smarter with our Oncotype IQ Genomic Intelligence Platform. This expanding suite of tissue- and liquid-based tests answers specific questions across the patient journey—from diagnosis through treatment and ongoing cancer management-through a single, trusted source easily accessed via our secure web-based platform for physicians to interpret and share results with patients.

Oncology and Urology Channels

Oncotype DX

Our flagship line of gene expression tests has been used to guide treatment decisions for more than 750,000 breast, colon, and prostate cancer patients worldwide.

Oncotype SEQ Liquid Select

A liquid biopsy tumor mutation panel that uses next-generation sequencing to identify select genomic alterations for the treatment of late-stage lung cancer. Learn more

Oncotype IQ Platform Evolution

Oncotype DX AR-V7 Nucleus Detect

Later this year, we are planning to launch a new liquid biopsy-based test, in collaboration agreement with Epic Sciences to help men with metastatic prostate cancer determine the most effective, life-sustaining therapy. Performed in Epic Science's CLIA-certified laboratory, the test will detect the expression of the androgen receptor protein (AR-V7) in the nucleus of circulating tumor cells. Learn more

The Road Ahead

Looking ahead, we will continue to expand our Oncotype IQ platform through internal development programs and strategic partnerships, all with the goal of making cancer care smarter.

Delivering Healthcare Savings

 

More than $100 Billion is spent each year on cancer care. Precision medicine can make a difference.

Did You Know?

Our flagship test, the Breast Recurrence Score, is an independent predictor of invasive breast cancer distant recurrence.

Learn More

Did You Know?

The Breast DCIS Score provides information beyond traditional measures.

Learn More

Stay in Touch

Have a specific question? Want to keep up with our latest news? We're here for you.

Contact Us
Making cancer care smarter.™